Multi-country Project on the Role of Diet, Food-related Behavior, and Obesity in the Prevention of Depression
NCT02529423 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1000
Last updated 2018-11-30
Summary
The study examines the feasibility and effectiveness of two different nutritional strategies (multi-nutrient supplement and food-related behavioural change) to prevent depression in high-risk overweight European Union citizens. Interventions will last 12 months. Design is a two-by-two factorial randomized controlled prevention trial with four intervention groups:
1. Control group (daily placebo supplements)
2. Multi-nutrient supplementation group (daily multi-nutrient supplement)
3. Food-related behavioural change group (food-related behavioural activation focusing on improving overall diet + placebo supplements)
4. Multi-nutrient supplementation + food-related behavioural activation group (daily multi-nutrient supplement + food-related behavioural activation focusing on improving overall diet).
Follow-up assessment will be conducted at 3, 6, and 12 months for primary and secondary endpoints, and during intervention for compliance, adverse events and mediating variables.Data will first be analyzed according to the intention-to-treat principle, using (mixed model) analysis of covariance with primary and secondary endpoints, testing for the effects of the two nutritional strategies separately as well as combined.
Conditions
Interventions
- DIETARY_SUPPLEMENT
-
Multi-nutrient supplement
* Omega 3 fatty acids * Folic acid * Calcium * Selenium * Vitamin D3
- BEHAVIORAL
-
Behavioral Activation
21 sessions (15 individual sessions and 6 group sessions) The intervention will include detailed analysis of each individual's behavior to determine idiosyncratic triggers and functions of unhelpful (e.g., mood-related snacking) and helpful food-related behavior, thereby, to reinforce helpful behaviors and to implement effective alternatives to unhelpful behaviors, building on behavioural approaches proven effective in depression.
- OTHER
-
Placebo
Placebo pills identical in look and taste but including no active ingredients
Sponsors & Collaborators
-
VU University of Amsterdam
collaborator OTHER -
University of Exeter
collaborator OTHER -
University of Leipzig
collaborator OTHER -
University of the Balearic Islands
lead OTHER
Principal Investigators
-
Marjolein Visser, PhD · VU University of Amsterdam
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- TRIPLE
- Model
- FACTORIAL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-07-31
- Primary Completion
- 2016-10-31
- Completion
- 2017-10-31
Countries
- Germany
- Netherlands
- Spain
- United Kingdom
Study Locations
More Related Trials
-
The Efficacy of Omega-3 Fatty Acids in Maintaining Optimal Mental Health in Elderly People
NCT00124852 ·Status: COMPLETED ·Phase: NA
-
Study of Supplementation of Antidepressants With Fish Oil to Improve Time to Clinical Response
NCT00963196 ·Status: WITHDRAWN ·Phase: NA
-
Polyunsaturated Fatty Acids (PUFA) Status and Cognitive Function in Healthy Young Adults
NCT01075958 ·Status: COMPLETED
-
Phospholipid Hypothesis of Depression: From Molecular Biology, Neuroimaging to Behaviour
NCT02615405 ·Status: COMPLETED ·Phase: NA
-
Omega-3 Fatty Acids in Adolescent Depression
NCT00312897 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of a Nutritional Supplement on Mental Wellness in Adults
NCT06058364 ·Status: COMPLETED ·Phase: NA
-
Omega-3 and Blueberry Supplementation in Age-Related Cognitive Decline
NCT01746303 ·Status: COMPLETED ·Phase: NA
-
The Effect of Long-Chain Polyunsaturated Fatty Acids on Cognitive Performance and Mood
NCT00615277 ·Status: COMPLETED ·Phase: NA
-
A Study of Omega-3 as a Treatment for Major Depression
NCT00238758 ·Status: UNKNOWN ·Phase: PHASE2
-
Omega-3 Fatty Acids as Adjunct Treatment for Major Depressive Disorder
NCT00511810 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Effects of DHA- and EPA-enriched Oils on Cognitive Function and Mood
NCT02763514 ·Status: COMPLETED ·Phase: NA
-
Investigating the Effects of Dietary Phospholipids on Measures of Human Brain Health and Psychological Wellbeing
NCT06107075 ·Status: RECRUITING ·Phase: NA
-
Essential Fatty Acids for Major Depression
NCT00256412 ·Status: COMPLETED ·Phase: NA
-
Intervening to Repair Cognitive and Behavioural Problems in Adults Exposed to Childhood Malnutrition
NCT04053218 ·Status: UNKNOWN ·Phase: PHASE3
-
A Prophylactic Trial of Omega-3 Polyunsaturated Fatty Acids in Bipolar Disorder
NCT04210804 ·Status: COMPLETED ·Phase: PHASE2
-
Omega-3 Fatty Acids for Treating Adults With Major Depression
NCT00517036 ·Status: COMPLETED ·Phase: PHASE3
-
Cytokines, PUFA Tissue Concentrations and Treatment Selection in Antenatal MDD
NCT03101540 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
The Role Of Omega-3 Fatty Acids In Adolescent Depression
NCT00962598 ·Status: COMPLETED ·Phase: PHASE2
-
Omega-3 Unsaturated Fatty Acid Improves Cognitive Function in Patients With Depression
NCT04803071 ·Status: UNKNOWN ·Phase: NA
-
The Effect of Fish Oil in Major Depressive Disorder
NCT00816322 ·Status: COMPLETED ·Phase: NA
-
Role of Omega-3 Polyunsaturated Fatty Acid in the Management of Major Depressive Disorder.
NCT03732378 ·Status: COMPLETED ·Phase: NA
-
Omega-3 for Depression and Other Cardiac Risk Factors - 2
NCT02021669 ·Status: COMPLETED ·Phase: PHASE2
-
PUFA Augmentation in Treatment of Major Depression
NCT00067301 ·Status: COMPLETED ·Phase: PHASE3
-
N-3 Fatty Acids as the First-line Antidepressant Therapy: From Biomarkers to Clinical Subtypes
NCT03871088 ·Status: COMPLETED ·Phase: NA
-
Effects of Fish-oil on Mood and Cognitive Functions of Healthy Individuals
NCT01104194 ·Status: COMPLETED ·Phase: NA